Modified coronavirus structural protein
US-2024226271-A1 · Jul 11, 2024 · US
Adiponectin-containing eating behavior control agent for oral administration
US9181561B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9181561-B2 |
| Application number | US-201013146575-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jan 18, 2010 |
| Priority date | Jan 29, 2009 |
| Publication date | Nov 10, 2015 |
| Grant date | Nov 10, 2015 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
Disclosed is a technique that facilitates the oral ingestion of adiponectin in a large quantity and enables the expansion of the range of use applications of adiponectin. Specifically disclosed is an appetite control agent for oral administration, which comprises adiponectin as an active ingredient. Particularly, the appetite control agent comprises a transformant capable of expressing adiponectin. Also specifically disclosed is a food composition for controlling appetite, which comprises the appetite control agent.
First claim
Opening claim text (preview).
The invention claimed is: 1. A method for preparation of an appetite enhancer for oral administration, comprising using a strawberry fruit of a transformed strawberry that expresses a gene encoding human adiponectin to prepare the appetite enhancer for oral administration. 2. The method according to claim 1 , wherein the transformed strawberry that expresses adiponectin is a transformed strawberry in which a gene consisting of (a) a DNA consisting of the ba…
Assignees
Inventors
Classifications
Patent family
Related publications grouped by family.
External sources
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US9181561B2 cover?
- Disclosed is a technique that facilitates the oral ingestion of adiponectin in a large quantity and enables the expansion of the range of use applications of adiponectin. Specifically disclosed is an appetite control agent for oral administration, which comprises adiponectin as an active ingredient. Particularly, the appetite control agent comprises a transformant capable of expressing adiponec…
- Who is the assignee on this patent?
- Matsumura Takeshi, Yasuno Rie, Sugimoto Chihiro, and 6 more
- What technology area does this patent fall under?
- Primary CPC classification C12N15/8257. Mapped technology areas include Chemistry & Metallurgy.
- When was this patent published?
- Publication date Tue Nov 10 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).